English Finnish
Published: 2024-03-20 08:30:00 CET
Biohit Oyj
Other information disclosed according to the rules of the Exchange
Publication of Biohit Oyj Remuneration Report 2023

Biohit Oyj Remuneration Report March 20, 2024 at 9:30 am local time (EET)

Biohit Oyj's Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at Biohit (biohithealthcare.com)

Additional information:

CEO Jussi Hahtela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is "Innovating for Health" - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Attachments:
Biohit Oyj Remuneration Report 2023.pdf

This news release was distributed by Company News System, www.nasdaqomxnordic.com/news/marketnotices
To subscribe on regulatory news from this company, go to the subscription page

Attachments

  • Original Link
  • Permalink

Disclaimer

Biohit Oyj published this content on 20 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 March 2024 07:49:01 UTC.